Ameriprise’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$42.9M Buy
999,132
+184,488
+23% +$7.93M 0.01% 953
2025
Q4
$35.7M Buy
814,644
+154,839
+23% +$6.41M 0.01% 1058
2025
Q3
$27.2M Sell
659,805
-62,695
-9% -$2.52M 0.01% 1199
2025
Q2
$31.8M Buy
722,500
+259,189
+56% +$10.4M 0.01% 1097
2025
Q1
$17.1M Sell
463,311
-470,364
-50% -$16.8M ﹤0.01% 1410
2024
Q4
$31.1M Sell
933,675
-657,315
-41% -$21.3M 0.01% 1097
2024
Q3
$41.3M Buy
1,590,990
+81,414
+5% +$2.02M 0.01% 932
2024
Q2
$33.9M Sell
1,509,576
-383,097
-20% -$8.5M 0.01% 983
2024
Q1
$44.9M Buy
1,892,673
+33,647
+2% +$748K 0.01% 851
2023
Q4
$44.6M Sell
1,859,026
-407,906
-18% -$8.87M 0.01% 828
2023
Q3
$49.5M Buy
2,266,932
+218,757
+11% +$4.58M 0.02% 742
2023
Q2
$39.2M Sell
2,048,175
-234,149
-10% -$4.51M 0.01% 882
2023
Q1
$44.3M Sell
2,282,324
-135,396
-6% -$2.36M 0.01% 809
2022
Q4
$38.8M Sell
2,417,720
-74,385
-3% -$1.21M 0.01% 840
2022
Q3
$39.1M Buy
2,492,105
+606,869
+32% +$11.7M 0.01% 804
2022
Q2
$39.3M Sell
1,885,236
-450,742
-19% -$9.29M 0.01% 827
2022
Q1
$53M Buy
2,335,978
+350,437
+18% +$6.84M 0.02% 782
2021
Q4
$36.3M Buy
1,985,541
+1,496,377
+306% +$28.6M 0.01% 994
2021
Q3
$10.3M Sell
489,164
-216,348
-31% -$4.02M ﹤0.01% 1836
2021
Q2
$12.9M Sell
705,512
-6,425
-0.9% -$150K ﹤0.01% 1715
2021
Q1
$16.1M Sell
711,937
-81,901
-10% -$1.85M 0.01% 1501
2020
Q4
$15.9M Buy
793,838
+68,796
+9% +$1.44M 0.01% 1400
2020
Q3
$17.7M Sell
725,042
-208,816
-22% -$4.87M 0.01% 1152
2020
Q2
$22.2M Buy
933,858
+159,170
+21% +$3.69M 0.01% 994
2020
Q1
$13.3M Buy
774,688
+35,463
+5% +$649K 0.01% 1191
2019
Q4
$13M Sell
739,225
-103,330
-12% -$1.75M 0.01% 1528
2019
Q3
$14.9M Sell
842,555
-43,140
-5% -$873K 0.01% 1371
2019
Q2
$18.9M Buy
885,695
+63,675
+8% +$1.33M 0.01% 1209
2019
Q1
$19.6M Sell
822,020
-4,859
-0.6% -$111K 0.01% 1157
2018
Q4
$16.3M Sell
826,879
-40,336
-5% -$719K 0.01% 1196
2018
Q3
$15.4M Buy
867,215
+762,313
+727% +$14.9M 0.01% 1524
2018
Q2
$2.26M Sell
104,902
-79,085
-43% -$1.64M ﹤0.01% 2687
2018
Q1
$4.07M Buy
183,987
+27,729
+18% +$766K ﹤0.01% 2317
2017
Q4
$4.75M Buy
156,258
+82,812
+113% +$2.2M ﹤0.01% 2178
2017
Q3
$1.78M Sell
73,446
-150,690
-67% -$4.01M ﹤0.01% 2672
2017
Q2
$5.52M Sell
224,136
-172,834
-44% -$3.66M ﹤0.01% 1991
2017
Q1
$8.6M Buy
396,970
+18,192
+5% +$370K ﹤0.01% 1647
2016
Q4
$5.65M Sell
378,778
-29,546
-7% -$426K ﹤0.01% 1951
2016
Q3
$5.22M Buy
408,324
+163,003
+66% +$1.76M ﹤0.01% 1954
2016
Q2
$1.92M Buy
+245,321
New +$1.41M ﹤0.01% 2548
2016
Q1
Sell
-132,410
Closed -$747K 3784
2015
Q4
$747K Sell
132,410
-47,246
-26% -$264K ﹤0.01% 3083
2015
Q3
$1.01M Buy
+179,656
New +$978K ﹤0.01% 2974
2014
Q4
Sell
-3,000
Closed -$5K 3929
2014
Q3
$5K Buy
3,000
+215
+8% +$690 ﹤0.01% 5136
2014
Q2
$9K Buy
2,785
+940
+51% +$3.25K ﹤0.01% 4719
2014
Q1
$7K Hold
1,845
﹤0.01% 4678
2013
Q4
$11K Sell
1,845
-11,714
-86% -$64.5K ﹤0.01% 4330
2013
Q3
$79K Buy
13,559
+257
+2% +$1.33K ﹤0.01% 3571
2013
Q2
$60K Buy
+13,302
New +$63K ﹤0.01% 3613

Other funds holding EXEL

Ameriprise's EXEL Position: Q1 2026 in Review

Ameriprise increased its Exelixis (EXEL) stake by 23% in Q1 2026, buying an estimated $7.93M and bringing the position to 999,132 shares worth $42.9M. The position accounts for 0.01% of the portfolio, ranked #953.

Ameriprise first reported a position in EXEL in Q2 2013 and has held it in 48 quarters since. The position peaked at $53M in Q1 2022. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Ameriprise held 999,132 shares of Exelixis worth $42.9M as of Q1 2026.
  • Ameriprise bought 184,488 Exelixis shares in Q1 2026, an estimated $7.93M.
  • Exelixis made up 0.01% of Ameriprise's portfolio in Q1 2026, its #953 holding.
  • Ameriprise first reported a position in Exelixis in Q2 2013 and has held it in 48 quarters since.
  • Ameriprise's Exelixis position peaked at $53M in Q1 2022.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.